光学活性3-(1′-羟基乙基)-4-乙酰氧基-β-内酰胺的立体选择性合成

(1′R,3R,4R)-N-取代-3-(1′-羟基乙基)-4-乙酰氧基-β-内酰胺(3)是合成青霉烯和碳青霉烯类β-内酰胺抗生素的关键中间体.以廉价的L-抗坏血酸为原料,制得S-缩异丙氧叉甘油醛(5),与胺反应定量转变成相应的手性亚胺(6a～6d),6与双烯酮[2+2]环加成反应,高立体选择性地合成3(S)-乙酰基-β-内酰胺(Sa～8d),其非对映体过量由类似反应的80％提高到接近100％.8a经四步反应得到目标化合物3a.     

(3S,6S)-及(3S,6R)-3-苄氧甲基-6-甲基-吗啉-2,5-二酮的 制备及其晶体结构

以2-溴丙酸和N-叔丁氧羰基-O-苄基-L-丝氨酸为起始试剂首先制得N-(2-溴丙基)-O-苄基-L-丝氨酸(BPBS), 在N,N-二甲基甲酰胺(DMF)/三乙胺(Et3N)溶剂中80 ℃经9 h后BPBS发生分子内环化反应生成(3S,6S)-3-苄氧甲基-6-甲 基-吗啉-2,5-二酮[(3S,6S)-BMMD]及(3S,6R)-BMMD共存体, 产率70%. 将所制得的共存体以乙酸乙酯为重结晶溶剂, 采用微分重结晶法, 经4次“溶解-部分重结晶”操作循环制得两种纯光学构型的(3S,6S)-BMMD和(3S,6R)-BMMD. 将两种光学纯双手性中心的BMMD分别溶于乙酸乙酯, 室温下培养得(3S,6S)-BMMD和(3S,6R)-BMMD的单晶体, 以X射线衍射法测定上述两种BMMD的分子结构.     

青霉烯和碳青霉烯类抗生素关键中间体——4-乙酰氧基氮杂环丁酮的立体选择性合成

以6,6-二溴青霉烷酸甲酯为原料经过氧化、格氏反应、还原、羟基保护、开环、甲基化、脱保护和乙酰化合成青霉烯和碳青霉烯类抗生素关键中间体4-乙酰氧基氮杂环丁酮(4-AA).该路线立体选择性非常好,避免了手性异构体的分离和重金属盐的使用,总收率30%.中间体及产品4-AA的结构均通过IR,MS,1HNMR和13CNMR确认.     

具有β-(1→6)-半乳吡喃糖骨架和α-L-(1→3)-阿拉伯呋喃糖侧链的阿拉伯半乳寡糖的简易合成

4-Methoxyphenyl glycoside of β-D-Galp-(1→6)-[α-L-Araf-(1→3)-]β-D-Galp-(1→6)-β-D-Galp-(1→6)-{β-D-Galp-(1→6)-[α-L-Araf-(1→3)-]β-D-Galp-(1→6)-β-D-Galp-(1→6)-}2β-D-Galp-(1→6)-[α-L-Araf-(1→)3)-]β-D-Galp-(1→)6)-β-D-Galp was synthesized with 2,3,4,6-tetra-O-benzoyl-α-D-galactopyranosyl trichloroacetimidate (1), 6-O-acetyl-2,3,4-tri-O-benzoyl-α-D-galactopyranosyl trichloroacetimidate (11), 4-methoxyphenyl 3-O-allyl-2,4-tri-O-benzoyl-β-D-galactopyranoside (2),isopropyl 3-O-allyl-2,4-tri-O-benzoyl--thio-β-D-galactopyranoside (12),4-methoxyphenyl 2,3,4-tri-O-benzoyl-β-D-galactopyranoside (5), and 2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl trichloroacetimidate (8) as the key synthons.     

Synthesis of propyl O-(α-L-rhamnopyranosyl)-(1→3)-[2,4-di-O-(2s-methylbutyryl)-α-L-rhamno-pyranosyl]-(1→2)-(3-O-acetyl-β-D-glucopyranosyl)-(1→2)-β-D-fucopyranoside,the tetrasaccharide moiety of Tricolorin A

Propyl O-(α-L-rhamncpyranosyl)-(1→3)-[2,4-di-O-(2s-methylbutyryl)-α-L-rham-nopyranosyl]-(1→2)-(3-O-acetyl-β-D-glucopyranosyl)-(1→2)-β-D-fucopyranoside (1), the tetrasac-charide moiety of Tricolorin A, was synthesized in total 23 steps with a longest linear sequence of 10 steps, and overall yield of 3.7% from D-Glucose. The isomerization of the dioxolane-type berzyli-dene in the presence of NIS/AgOTf was observed. Tetrasaccharide 1 exhibited no activity against the cultured P388 cell as Tricolorin A did.     

双环[10,3,0]十五碳-1(12)-烯-13-酮系列化合物的合成

以多聚磷酸为催化剂,通过环十二碳烯和α,β-不饱和酸的反应,合成了十个双环[10.3.0]十五碳-1(12)-烯-13-酮系列化合物,研究了合成反应的条件及产物的分离提纯方法,并测定了它们的紫外光谱、红外光谱以及~1H核磁共振谱。     

螺环倍半萜(±)-α-花柏烯-3-酮的全合成

通过萜品油烯 ( Terpinolene)与 2 ,4-二氧代戊酸甲酯的 de Mayo反应得到 [2 +2 ]光加成产物 ,经反aldol重排 ,再环合成具有螺 [5 ,5 ]十一烷结构的花柏烯基本碳架 ,进而对其官能团进行化学修饰 ,完成了螺环倍半萜 (± ) -α-花柏烯 -3 -酮的全合成 .     

D-(R)-酪氨酸的不对称催化氢化合成及其在药物合成中的应用

以最近开发的双膦-铑配合物[Rh((R,R)-QuinoxP*)(cod)]SbF6作为催化剂,利用不对称催化氢化方法合成了一系列D-(R)-酪氨酸衍生物,在S/C=10000条件下获得了99%ee的对映选择性.并将所得的氢化产物成功应用于具有重要生理活性的化合物(R)-2-羟基-3-(3,4-二羟基苯基)丙酸钠的合成.相比于已报道的方法,该工艺路线产率更高而且不需要柱层析分离,因而非常具有工业化应用前景.     

3-(2-羟基苯基)-5-苯基-6-乙氧羰基-2-环己烯酮的合成与晶体结构

合成了3-(2-羟基苯基)-5-苯基-6-乙氧羰基-2-环己烯酮.通过元素分析、红外光谱、紫外光谱、核磁共振氢谱和质谱对其组成和结构进行了表征.利用X射线衍射分析方法测定了它的晶体结构.该化合物的晶体属单斜晶系,空间群P21/c,a=1.41946(17)nm,b=0.58445(7)nm,c=2.1756(3)nm,β=104.795(2)°,V=1.7450(4)nm3,Z=4,Dc=1.280 g·cm-3,F(000)=712,μ=0.088mm-1,R1[I＞2σ(I)]=0.0627,wR2[I＞2σ(I)]=0.1484.晶体结构测定结果表明化合物分子中的环己烯部分为半椅式构象,分子间通过氢键形成具有16元环的二聚体.     

6-溴甲基-2-甲基-3(H)-喹唑啉-4-酮的合成

6-溴甲基-2-甲基-3(H)-喹唑啉-4-酮(见图1所示)是治疗晚期结肠癌和直肠癌的一线药物雷替曲赛(Raltitrexed)[1～3]的重要中间体.Raltitrexed是由英国AstraZeneca公司开发的胸苷酸合成酶抑制剂,已经在全球主要发达国家上市.Raltitrexed可以选择性地抑制胸苷酸合酶(thymidylate synthase,TS),干扰TS正常的生理功能,抑制DNA的合成,进而起到抑制肿瘤细胞生长或增殖的作用[4～5].     

Synthesis of (5R,8S,10R)-6-(Allyloxy)- and (5R,8S,10R)-6-(Propyloxy)ergolines from the 6-Methyl Precursors

Novel (5R,8S,10R)-6-(allyloxy)- and (5R,8S,10R)-6-(propyloxy)ergolines have been synthesized by use of a Meisenheimer [2,3]-sigmatropic rearrangement of a (5R,8S,10R)-6-allyl-ergoline N⁶-oxide as key step.     

Synthesis of D-(6R) - and D-(6S) -(6-2H1) glucose

Chemical synthesis ofD-(6R)- and D(6S)-(6-²H₁) glucose is described comprising (i) formation of 6-²H₁)-3-o-benzyl-5,6-dideoxy-l, 2-0-isopropylidene-α-D-xylo-hex-5-ynofuranose from D-glucose; (ii) stereospecific reduction of the deuterated acetylene functionality to (E)- or (Z)-deuterated olefin; (iii) stereospecific cis-dihydroxylation of the deuterated olefin; and (iv) separation of stereoisomers based on the intrinsic chirality of D-glucose and subsequent deprotection.     

Facile Syntheses of (6S)-6-Fluoroshikimic Acid and (6R)-6-Hydroxyshikimic Acid

ＩｎｔｒｏｄｕｃｔｉｏｎＴｈｅｓｈｉｋｉｍａｔｅｐａｔｈｗａｙｉｓａｎｉｍｐｏｒｔａｎｔｂｉｏｓｙｎ ｔｈｅｔｉｃｓｅｑｕｅｎｃｅｉｎ ｐｌａｎｔｓ ,ｆｕｎｇｉａｎｄｍｉｃｒｏｏｒｇａｎｉｓｍｓｆｏｒｔｈｅｃｏｎｖｅｒｓｉｏｎｏｆｃａｒｂｏｈｙｄｒａｔｅｓｔｏｔｈｅａｒｏｍａｔｉｃａｍｉｎｏａｃｉｄｓ (Ｌ ｐｈｅｎｙｌａｌａｎｉｎｅ ,Ｌ ｔｙｒｏｓｉｎｅａｎｄＬ ｔｒｙｐｔｏｐｈａｎ)ａｎｄｐｒｅｃｕｒｓｏｒｓｔｏｔｈｅｆｏｌａｔｅｃｏｅｎｚｙｍｅｓ ,ａｌｋａｌｏｉｄｓａｎｄｖｉｔａｍｉｎｓ[1] .Ａｓ…     

Asymmetric Synthesis of (-)-(2R,3R,6S)-Irnigaine

Introduction　　Asarelativelynewmemberofnaturalalkaloidswith2 ,6 disubstituted 3 piperidinolskeleton ,irnigaine 1wasisolatedfromthetubersofArisarumVulgare (Araceae)in1995byMelhaouiandBode .1Itsstructureandrelativeconfigurationswereelucidatedby1HNMRstudiesandtheabsoluteconfigurationwasproposedonthebasisofitsopti calrotation .1Soonafterthen ,Meyerandhisco workersreportedthefirstsynthesisof (- ) (2R ,3R ,6S) irni gaineandtheconfigurationconfirmation .Althoughtheirsynthesisroutewasshortan…     

(1R,6R)-(+)-鱼腥藻毒素的合成

鱼腥藻毒素(Anatoxin-a)是自兰藻类水华鱼腥藻(Anabaena flos-aquae)中分离的一种氮杂双环胺类生物碱,其化学结构及绝对构型经X光晶体衍射法测定分析为:(1R,6R)(+)-2-乙酰基-9-氮双环[4.2.1]壬-2-烯,简称为AnTX-a。     

Esters of (R)-2-(6-hydroxynaphthalene-2-yl)octane

New chiral liquid crystals containing (R)-1-methylheptyl chain attached directly to aromatic ring were derived from naproxen. Temperature and heat of phase transitions as well as phase sequence were determined.     

Convenient synthesis of （2S,3R,4R,5S,6R）-2-（3-（4-ethylbenzyl）-4- chlorophenyl）-6-（hydroxymethyl）-tetrahydro- 2H-pyran-3,4,5-triol

A convenient approach for the preparation of （2S,3R,4R,5S,6R）-2-（3-（4-ethylbenzyl）-4-chlorophenyl）-6-（hydroxymethyl）- tetrahydro-2H-pyran-3,4,5-triol I is developed. The target compound via four steps is synthesized from 4-bromo-2-（bromomethyl）- 1-chlorobenzene and the isomers of undesired ortho-products were avoided during the preparation.     

Synthesis and Conformation of (5R,8R,10R)-8-(Methylthiomethyl)ergoline-6-carboxamidine

The title compound 7 and two related novel ergolines have been synthesised from (5R,8R,10R)-8-(methyl-thiomethyl)ergoline-6-carbonitrile ( 4 ). The guanidine function of 7 induces a boat conformation of ergoline-ring D, as demonstrated by a careful NMR spectroscopic analysis of 7 and its N-hydroxy congener 6 . Diphenylphosphinodithioic acid has been used to convert the cyanamide function of 4 into the thiourea function at (5R,8R,10R)-8-(methylthiomethyl)ergoline-6-thiocarboxamide ( 5 ).